Home    Back

Xanthohumol    (DrugBank: Xanthohumol)

1 disease
IDDisease name (Link within this page)Number of trials
96Crohn disease1

96. Crohn disease    [ 2,209 clinical trials,   1,276 drugs,   (DrugBank: 240 drugs),   166 drug target genes,   210 drug target pathways]
Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 2,209 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04590508
(ClinicalTrials.gov)		October 1, 202028/9/2020Xanthohumol Metabolism and Signature (XMaS) in Crohn's DiseaseXanthohumol Metabolism and Signature (XMaS) in Crohn's DiseaseCrohn DiseaseDrug: Xanthohumol;Other: PlaceboNational University of Natural MedicineOregon State University;Pacific Northwest National LaboratoryRecruiting21 Years50 YearsAll32Phase 2United States